$484.52
Value $3.60T
MSFT and ZEPP stock compared: price, dividend, valuation and results, from SEC filings.
$484.52
Value $3.60T
$2.31
Value $37M
Microsoft (MSFT) has a market value of $3.60T and Zepp Health (ZEPP) $37M. Over the last year, with dividends, MSFT moved +0.5% and ZEPP -90.4%. Dividend yield: MSFT 0.77%, ZEPP none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MSFT$3.60T
ZEPP$37M
MSFT is 97,944 times ZEPP
Revenue, 12 months
MSFT$346B
ZEPP$259M
MSFT is 1,338 times ZEPP
Net income, 12 months
MSFT$143B
ZEPP-$40M
Operating margin
MSFT47.1%
ZEPP-11.3%
58.4 points apart
ROIC
MSFT28.7%
ZEPP-6.0%
34.7 points apart
P/E
MSFT25.2
ZEPP–
Dividend yield
MSFT0.8%
ZEPP0.0%
0.8 points apart
5-year return
MSFT+47.2%
ZEPP-92.3%
139.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MSFT+47.2%
ZEPP-92.3%
| Period | MSFTWith dividends | ZEPPWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | +0.5%Price -0.5% | -90.4%Price -90.4% |
| 3 years since November 20, 2023 | +31.4%+9.5% a yearPrice +28.4% | -57.2%-24.7% a yearPrice -57.2% |
| 5 years since November 19, 2021 | +47.2%+8.0% a yearPrice +41.2% | -92.3%-40.1% a yearPrice -92.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MSFTMicrosoftZEPPZepp Health
| Price | $484.52 | $2.31 |
|---|---|---|
| Market value | $3.60T | $37M |
| Enterprise value (EV) | $3.64T | $151M |
| P/E | 25.2 | – |
| P/E, 5-year median | 35.2 | – |
| P/B | 7.7 | 0.2 |
| EV/EBIT | 22.3 | – |
| Free cash flow yield | 1.7% | – |
| Revenue, 12 months | $346B | $259M |
|---|---|---|
| Net income, 12 months | $143B | -$40M |
| Free cash flow, 12 months | $60.0B | -$26M |
| Earnings per share, 12 months | $19.16 | -$2.56 |
| Revenue growth, year on year | 17.8% | 41.8% |
| Revenue growth a year, past | +14.6%over 5 years | -23.5%over 5 years |
| EPS growth a year, past | +17.4%over 5 years | – |
| Gross margin | 67.7% | 38.3% |
|---|---|---|
| Operating margin | 47.1% | -11.3% |
| Net margin | 41.2% | -15.5% |
| ROIC | 28.7% | -6.0% |
| ROE | 34.3% | -18.7% |
| Cash | $64.5B | $57M |
|---|---|---|
| Total debt | $134B | $173M |
| Net debt / EBITDA | 0.2 | – |
| Interest cover | 50.6× | -5.1× |
| Dividend yield | 0.8% | – |
|---|---|---|
| Dividend per share, 12 months | $3.71 | – |
| Dividend growth a year, past | +10.2%over 5 years | – |
| Buyback yield | 0.6% | 3.4% |
| Shareholder yield | 1.4% | 3.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Microsoft ($3.60T) is about 97,943.9 times Zepp Health ($37M), at today's prices.
Since November 19, 2021, MSFT's price moved +41.2% and ZEPP's -92.5%. With dividends: MSFT +47.2% (+8.0% a year), ZEPP -92.3% (-40.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is 0.77% for Microsoft and none for Zepp Health. Over the last twelve months they paid $3.71 and – per share.
Over the last twelve months, the net margin was 41.2% for Microsoft and -15.5% for Zepp Health, and the operating margin 47.1% and -11.3%. Revenue was $346B and $259M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.